HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 182 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $16,653,648 | -6.7% | 508,198 | +0.2% | 0.01% | 0.0% |
Q2 2023 | $17,853,083 | +33.1% | 507,334 | +23.5% | 0.01% | +20.0% |
Q1 2023 | $13,417,093 | -28.4% | 410,937 | +20.8% | 0.01% | -28.6% |
Q4 2022 | $18,739,675 | +1.8% | 340,103 | -18.1% | 0.01% | 0.0% |
Q3 2022 | $18,400,000 | -2.5% | 415,451 | +7.4% | 0.01% | 0.0% |
Q2 2022 | $18,870,000 | -0.5% | 386,912 | -0.7% | 0.01% | +16.7% |
Q1 2022 | $18,962,000 | -20.6% | 389,760 | -30.4% | 0.01% | -14.3% |
Q4 2021 | $23,873,000 | -6.7% | 559,868 | -16.2% | 0.01% | 0.0% |
Q3 2021 | $25,596,000 | +34.0% | 667,784 | -1.3% | 0.01% | +16.7% |
Q2 2021 | $19,101,000 | -4.4% | 676,620 | +11.9% | 0.01% | 0.0% |
Q1 2021 | $19,985,000 | +7.6% | 604,865 | +17.8% | 0.01% | 0.0% |
Q4 2020 | $18,566,000 | +66.1% | 513,570 | +55.8% | 0.01% | +50.0% |
Q3 2020 | $11,176,000 | – | 329,668 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Valor Management LLC | 11,218,033 | $618,113,619 | 97.50% |
venBio Partners LLC | 1,035,396 | $57,050,320 | 17.69% |
Vivo Capital, LLC | 2,606,247 | $143,604 | 16.53% |
Nan Fung Group Holdings Ltd | 368,665 | $20,313,442 | 14.00% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 264,500 | $14,560,725 | 4.50% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 685,340 | $37,762,234 | 3.51% |
ASHFORD CAPITAL MANAGEMENT INC | 356,638 | $19,650,754 | 3.05% |
TANG CAPITAL MANAGEMENT LLC | 281,200 | $15,494,120 | 2.25% |
MPM BioImpact LLC | 139,377 | $7,679,673 | 1.99% |
O'Neil Global Advisors, Inc. | 7,335 | $404 | 1.86% |